Former CP3 Faculty Affiliate Dr. Utibe Essien coined the term "pharmacoequity" to describe a health system where all patients have access to the highest quality, evidence-based medical care. To advance the goal of achieving such a system, our faculty conduct research that informs ways to increase access to and cost burden from health services and medications and to decrease bias in health care and research. These are active pharmacoepidemiology projects conducted by our faculty. Read more about pharmacoequity in our JAMA Viewpoint.
All published work in pharmacoequity
Pharmacoequity Conference
